Form 4: Horizon Kinetics Buys RCG Shares

Horizon Kinetics Asset Management LLC reports a significant acquisition of common stock in RCG Fund, Inc., increasing its beneficial ownership.

Summary

• Horizon Kinetics Asset Management LLC (HKAM) acquired 756 shares of RCG Fund, Inc. (RCG) common stock on June 15, 2026.
• The purchase was made at a price of $2.85 per share.
• Following this transaction, HKAM beneficially owns 920,568 shares of RCG common stock.
• HKAM serves as the investment adviser to RCG and has a pecuniary interest in the shares through various managed accounts.
• HKAM is a wholly owned subsidiary of Horizon Kinetics Holding Corporation.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates an investment adviser increasing its stake, but it does not provide operational or financial performance data.

Positives

• Increased beneficial ownership by an investment adviser, potentially indicating confidence in the issuer.
• The acquisition of shares at $2.85 per share suggests a belief in the current valuation or undervaluation of RCG.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are crucial for tracking insider transactions, which can provide insights into management's perception of a company's value. Horizon Kinetics Asset Management's increased stake in RCG Fund, Inc. may signal a positive view on the fund's prospects.

Stakeholder Impact

• Shareholders may view the increased stake by the investment adviser positively, potentially indicating confidence in the fund's future performance.
• Other stakeholders will not be directly impacted by this specific transaction, as it is a change in beneficial ownership rather than a strategic operational change.

Key Dates

Keywords

RCG, Horizon Kinetics Asset Management, Form 4, beneficial ownership, common stock, insider trading, investment adviser